In a major initiative designed to accelerate global research efforts, Australia’s Biotechnology Centre of Excellence, the National Stem Cell Centre (NSCC) today announced it plans to collaborate with biotechnology company Stem Cell Sciences Ltd (SCS) to allow the development and distribution of new human embryonic stem (ES) cell lines to scientists around the world.
Based on a Heads of Agreement that has been reached, the new lines of stem cells will be obtained from Melbourne IVF clinics by SCS, subject to the issue of an appropriate NHMRC license as required by Australian law. It is hoped that six new lines will be developed over a two year period. Both the NSCC and SCS will then use the new human ES cell lines to accelerate their own research programs which focus on significant illnesses with limited treatments.
Download the full media release below.
Downloads
Major Boost for Stem Cell Research (35691)
Other Reports